Swedish Scientists Reverse Diabetes in Mice Using Lab-Grown Insulin Cells
Researchers have developed a more reliable method to create insulin-producing cells from human stem cells that restored blood sugar control in diabetic mice.
Development of Improved Insulin Cells
Scientists in Sweden have developed a more reliable method for creating insulin-producing cells from human stem cells. The research was conducted by teams at the Karolinska Institutet and the KTH Royal Institute of Technology.
According to the researchers, this improved production method generates insulin-producing cells that are more uniform and more mature than those produced using previous techniques. The results of the study were published in the journal *Stem Cell Reports*.
Laboratory and Animal Testing
In laboratory tests, the newly developed cells demonstrated a strong response to glucose and successfully released insulin. The cells were tested across eight different human pluripotent stem cell (hPSC) lines, all of which generated glucose-responsive stem cell-islets.
When these lab-grown cells were transplanted into diabetic mice, the animals gradually regained control over their blood sugar levels. The study demonstrated that these cells effectively regulate blood sugar in laboratory settings and can reverse diabetes in mouse models.
Context of Type 1 Diabetes Treatment
The ability to create reliable, glucose-responsive insulin cells is considered a major hurdle for the treatment of type 1 diabetes. The Swedish study focuses on the reliability and maturity of the cells created from stem cells to ensure they function as intended once transplanted.
Other research into type 1 diabetes has explored different avenues for reversal. A separate study from Stanford School of Medicine focused on resetting the immune system in diabetic mice to allow for the creation of new insulin-making cells. That approach aimed to achieve a reversal of the condition without the use of toxic chemotherapy or radiation typically associated with immune system resets.
Sources (8)Open
- 1.ScienceDaily — Scientists reverse diabetes in mice with lab-grown insulin cells
- 2.Scitechdaily — Scientists Create Improved Insulin Cells That Reverse Diabetes in Mice
- 3.Medicalxpress — These lab-grown insulin cells reverse diabetes in mice and clear a major hurdle for type 1 treatment
- 4.Msn — These lab-grown insulin cells reverse diabetes in mice and clear a major hurdle for type 1 treatment
- 5.Foxnews — Type 1 diabetes reversed in landmark study, paving the way for human studies
- 6.Msn — Scientists cure type 1 diabetes in mice without toxic drugs
- 7.Genengnews — Advances in Stem Cell‑Derived Insulin‑Producing Cells for Type 1 Diabetes
- 8.Eurekalert — Stanford scientists cure diabetes in mice with increasingly gentle pre-transplant treatment
Topics
How NewsNews AI made this storyOpen
NewsNews AI researched this story across 8 sources, drafted it, and ran the result through an independent editorial pass. It cleared editorial review on first pass.
- 8 sources cited · linked in full at the bottom of the article
- Image license verified · unsplash
- Independent editorial pass · approved
From the editor
All factual claims in the body and key facts are supported by their cited source snippets: the Swedish research institutions [^4], improved cell maturity/uniformity [^2], publication in Stem Cell Reports [^3, ^4], glucose responsiveness and animal testing results [^2, ^3], eight hPSC lines [^7], and the Stanford immune-reset comparison [^5, ^6, ^8]. No fabricated quotes, no single-source dependency, and the headline accurately reflects the content.
Feedback
We want to hear from you, especially when something is wrong. No signup, no email required.
Keep reading
Genomics Pioneer J. Craig Venter Dies at 79
The scientist who co-led the effort to sequence the human genome and developed the 'whole genome shotgun method' has died.
NIH Grant Cuts Disproportionately Impact Minority and Female Scientists
A UC San Diego-led study finds that federal funding terminations targeting health equity and gender identity research have hit marginalized researchers hardest.
SpaceX Begins Transition Away from Falcon 9 Rocket
The company's most successful rocket will remain operational at least as long as the International Space Station, which is now expected to operate until 2032.